Cannabist aims to restore empathy in medicine to improve patient outcomes and overall health and wellness. Our patient-centric focus includes one-on-one consultations and follow-ups with our experts, enabling individualized care on your personal health and wellness journey.
With a focus on clean cultivation, superior quality, and positive patient outcomes, we offer brands and products that meet high standards of potency, purity, and predictability.
Our proprietary, patient-pending medical brands define Medical Cannabis. Theraceed, Claraceed, and Eleceed are pharmaceutical-quality and come in a variety of formats, including capsules, tinctures, and vapes, with new products being added frequently.
OUR VISION: To solve some of the world’s most challenging unmet medical needs.
OUR MISSION: Improve lives through product innovation, research and patient experience.
OUR VALUES: Patient-Centered, Caring, Collaborative, Honorable, Accountable, Innovative, Grateful
UNIVERSITY PARTNERSHIPS
We have established partnerships with some of the world’s leading research institutions, universities, and medical schools to further medical cannabis research, allowing for timely and relevant data collection and analysis, to drive future innovation.
PROPRIETARY DATA
We analyze patient and research data to identify new insights, that enable innovation in patient care and treatment, leading to new IP and improved patient experiences.
RELENTLESS INNOVATION
From products to service, we innovate to provide better products, patient experiences, and better patient outcomes.
LEADING THE INDUSTRY
Cannabist is leading the industry in product quality and expertise, as well as removing barriers to access for medical cannabis.
From introducing the U.S.’s first legal credit card for cannabis purchases, to starting the 100 million ways to break the opioid crisis research initiative, to advocating for access for patients of all types around the U.S. and the world, we have led the way in this industry and will continue to do so for the good of our business and our patients. As an experienced multi-state operator, some of our key achievements include six-plus years of strong organic growth, 1 million patient sales transactions, 63 facilities in operation or development, and 39 licenses in 15 markets.
